Research Article
Coil Embolization for Coronary Artery Perforation: A Retrospective Analysis of 110 Patients
Table 1
Baseline clinical characteristics and medication.
| | 110 patients |
| | Clinical | | Age (years) | 75.9 ± 9.7 | | Male sex, n (%) | 69 (72.7%) | | Body mass index (kg/m2) | 23.2 ± 3.3 | | Hypertension, n (%) | 77 (70.0%) | | Hyperlipidemia, n (%) | 75 (68.2%) | | Diabetes mellitus, n (%) | 40 (36.4%) | | Smoker, n (%) | 56 (50.9%) | | Hemodialysis, n (%) | 13 (11.8%) | | Old myocardial infarction, n (%) | 43 (39.1%) | | Prior history of PCI, n (%) | 69 (62.7%) | | Prior history of CABG, n (%) | 14 (12.7%) | | Atrial fibrillation, n (%) | 27 (24.5%) | | Peripheral artery disease, n (%) | 11 (10.0%) | | Stroke, n (%) | 10 (9.1%) | | COPD, n (%) | 4 (3.6%) |
| | Clinical diagnosis | | Stable angina, n (%) | 106 (96.4%) | | Unstable angina, n (%) | 4 (3.6%) |
| | Laboratory data | | LDL cholesterol (mg/dl) | 99.6 ± 35.7 | | HbA1c (%) | 6.1 ± 0.8 | | eGFR (mL/min/1.73 m2) | 52.8 ± 24.9 | | eGFR <30 mL/min/1.73 m2, n (%) | 21 (19.1%) | | eGFR <60 mL/min/1.73 m2, n (%) | 61 (55.5%) | | Left ventricular ejection fraction (%) | 58.5 ± 12.8 |
|
|
Values are expressed as numbers (%) or means (±SD). PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; COPD, chronic obstructive pulmonary disease; LDL, low-density lipoprotein; eGFR, estimated glomerular filtration rate.
|
